Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of kinase inhibitors for cancer treatment. Its fluorinated aromatic structure enhances binding selectivity and metabolic stability in drug candidates. Commonly employed in the preparation of active pharmaceutical ingredients (APIs) requiring fluorophenyl scaffolds for improved bioavailability and target affinity. Also utilized in research settings for designing novel anti-inflammatory and antiviral agents.